Table 1 Primer sequences used for RT-PCR
From: Upregulated expression of FGF13/FHF2 mediates resistance to platinum drugs in cervical cancer cells
Target* | Primer sequences (5′ to 3′) | Product size (bp) |
|---|---|---|
hFGF13 (all variants) | Forward 5′- ACAAGCCTGCAGCTCATTTT -3′ |  |
|  |  Reverse 5′- CTTTTGCCCTCACTGGCTAC -3′ | 192 |
hFGF13v1 | Forward 5′- GGAGGAGCTCGGACGGCATGC -3′ |  |
|  |  Reverse 5′- ATAGCCGCCGCCATGGCCAC -3′ | 204 |
hFGF13v2/3/5 | Forward 5′- CCCTTTCGTGCTAAGTGTCA -3′ |  |
|  |  Reverse 5′- CTTAAGCTGAGGCTCTTCCG -3′ | 92 |
hFGF13v4 | Forward 5′- GCGGTGGGGAAAAGCGGATTC -3′ |  |
|  |  Reverse 5′- AAGCTGAGGCTCCTTAGAAGC -3′ | 197 |
hFGF13v6 | Forward 5′- CTCTGTGTCTGCTCCAAATGT -3′ |  |
|  |  Reverse 5′- GGGATGAGGTTAAACAGAGTG -3′ | 219 |
hSLC7A11 | Forward 5′- CTGGAGACCTCGACAGCAGTCTTTT -3′ |  |
|  |  Reverse 5′- ACTCCAGTCAGAGTGATGACGA -3′ | 238 |
hGAPDH | Forward 5′- CTGACCTGCCGTCTAGAAAAAC -3′ |  |
|  |  Reverse 5′- GTCTCTCTCTTCCTCTTGTGCTCT -3′ | 325 |
mFgf13 | Forward 5′- CCTCGGAACATTTCACACCT -3′ |  |
|  |  Reverse 5′- AGTGGTTTGGGCAGAAAATG -3′ | 199 |
mSlc7A11 | Forward 5′- TCCTCTGCCAGCTGTTATTG -3′ |  |
|  |  Reverse 5′- GAGAGGCACCTTGAAAGGAC -3′ | 184 |
mGapdh | Forward 5′-CCCCTTCATTGACCTCAACTAC-3′ |  |
|  |  Reverse 5′-TGGTGGTGAAGACACCAGTAGA-3′ | 209 |
